Brin, M. F., & Blitzer, A. (2023). The pluripotential evolution and journey of Botox (onabotulinumtoxinA). Medicine, 102(S1), e32373. https://doi.org/10.1097/md.0000000000032373

Carruthers, J., Carruthers, A., Blitzer, A., Eadie, N., & Brin, M. F. (2023). Treatment of glabellar lines with Botox (onabotulinumtoxinA): Development, insights, and impact. Medicine, 102(S1), e32375. https://doi.org/10.1097/md.0000000000032375

Gormley, M., Chambers, H. G., Kim, H., Leon, J., Dimitrova, R., & Brin, M. F. (2023). Treatment of pediatric spasticity, including children with cerebral palsy, with Botox (onabotulinumtoxinA): Development, insights, and impact. Medicine, 102(S1), e32363. https://doi.org/10.1097/md.0000000000032363

Hirschtritt, M. E., Slama, N., Sterling, S. A., Olfson, M., & Iturralde, E. (2021). Psychotropic medication prescribing during the COVID-19 pandemic. Medicine, 100(43), e27664. https://doi.org/10.1097/md.0000000000027664

Riyahi, S., Hectors, S. J., Prince, M. R., Sweeney, E. M., Lane, E. G., Honya, R., & Margolis, D. J. (2021). Predictors of acute deep venous thrombosis in patients hospitalized for COVID-19. Medicine, 100(38), e27216. https://doi.org/10.1097/md.0000000000027216